Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:38:29.879Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:38:29.879Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ef632b76806419539d367682e283305f5302e219c84c42b2c880863f64fefb48
FORWARD PE RATIO
N/A
Shuttle Pharmaceuticals Holdings, Inc.
Market Cap
$2.38M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | $2.38M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.37M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
